Jeff Yass’s Aethlon Medical AEMD Stock Holding History

Jeff Yass’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23	Closed	-$54K	–	12279
2022 Q3	$54K	Buy	+23	New	+$99.5K	﹤0.01%	12144
2021 Q4	–	Sell	-11	Closed	-$166K	–	13031
2021 Q3	$166K	Buy	+11	New	+$185K	﹤0.01%	11694

Other funds holding AEMD

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jeff Yass's AEMD Position: Q3 2024 in Review

Jeff Yass sold out of Aethlon Medical (AEMD) in Q3 2024, closing a stake of 92 shares — an estimated $18.3K sold.

Jeff Yass first reported a position in AEMD in Q2 2018 and held it in 7 quarters. The position peaked at $66K in Q2 2018. 12 funds tracked by Wall St. Rank hold AEMD as of Q3 2024.

Jeff Yass reported no remaining Aethlon Medical position as of Q3 2024 after selling out during the quarter.
Jeff Yass sold 92 Aethlon Medical shares in Q3 2024, an estimated $18.3K.
Jeff Yass first reported a position in Aethlon Medical in Q2 2018 and held it in 7 quarters.
Jeff Yass's Aethlon Medical position peaked at $66K in Q2 2018.
12 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.